Vacuna contra el virus del papiloma humano

The human papillomavirus (HPV) causes the most common sexually transmitted viral infection in the world. To date, about 200 types of HPV have been identified. The fundamental purpose of vaccination is to prevent infection by the Human Pap-illomavirus, which is responsible for Cervical Cancer, genita...

Full description

Saved in:
Bibliographic Details
Main Authors: Ostaiza Moreira, Joseph Leonardo, Morales Pacheco, Angie Mishel, Morán Romero, Hjalmar Roberto, Cueva Fajardo, Angie Yarel
Format: Article
Language:Spanish
Published: 2022
Subjects:
Online Access:https://dialnet.unirioja.es/servlet/oaiart?codigo=8512304
Source:RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 3, 2022, pags. 175-182
Tags: Add Tag
No Tags: Be the first to tag this record
id
dialnet-ar-18-ART0001539851
record_format
dialnet
institution
Dialnet
collection
Dialnet AR
source
RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 3, 2022, pags. 175-182
language
Spanish
topic
Vacuna
Cáncer
Cuello
Útero
Sexual
Vaccine
Cancer
Neck
Uterus
Sexual
spellingShingle
Vacuna
Cáncer
Cuello
Útero
Sexual
Vaccine
Cancer
Neck
Uterus
Sexual
Ostaiza Moreira, Joseph Leonardo
Morales Pacheco, Angie Mishel
Morán Romero, Hjalmar Roberto
Cueva Fajardo, Angie Yarel
Vacuna contra el virus del papiloma humano
description
The human papillomavirus (HPV) causes the most common sexually transmitted viral infection in the world. To date, about 200 types of HPV have been identified. The fundamental purpose of vaccination is to prevent infection by the Human Pap-illomavirus, which is responsible for Cervical Cancer, genital warts and other types of cancer common in genital regions, also reduce the incidence of morbidity and mortality from Neck Cancer. The methodology used for this research work is part of a bibliographic review of a documentary type, since we are going to deal with issues raised at a theoretical level such as the Vaccine against the human papillomavirus. The technique for data collection is made up of electronic materials, the latter such as Google Scholar, PubMed, among others, relying on the use of descriptors in health sciences or MESH terminology. The information obtained here will be reviewed for further analysis. HPV is not an uncommon virus, it is present in both men and women, despite the fact that, in most cases, after a while the virus can disappear on its own, if it persists, without the knowledge in this The case of women can trigger more serious lesions in a period of up to 10 years, such as cervical cancer, cervical cancer, and minor lesions such as warts on the genitals. The HPV vaccine has existed for more than a decade, however, the lack of knowledge about the consequences that this pathology can trigger, together with cul-tural beliefs, parental skepticism, low education, among other aspects, have made the applicability of the vaccine complex. vaccine that the WHO recommends starting at 9 years of age, to once and for all protect adolescents from the onset of sex-ual intercourse, the effectiveness of the vaccine is proven to be more than 90% when the dose is applied recommended
format
Article
author
Ostaiza Moreira, Joseph Leonardo
Morales Pacheco, Angie Mishel
Morán Romero, Hjalmar Roberto
Cueva Fajardo, Angie Yarel
author_facet
Ostaiza Moreira, Joseph Leonardo
Morales Pacheco, Angie Mishel
Morán Romero, Hjalmar Roberto
Cueva Fajardo, Angie Yarel
author_sort
Ostaiza Moreira, Joseph Leonardo
title
Vacuna contra el virus del papiloma humano
title_short
Vacuna contra el virus del papiloma humano
title_full
Vacuna contra el virus del papiloma humano
title_fullStr
Vacuna contra el virus del papiloma humano
title_full_unstemmed
Vacuna contra el virus del papiloma humano
title_sort
vacuna contra el virus del papiloma humano
publishDate
2022
url
https://dialnet.unirioja.es/servlet/oaiart?codigo=8512304
_version_
1767464032553402368
spelling
dialnet-ar-18-ART00015398512023-05-30Vacuna contra el virus del papiloma humanoOstaiza Moreira, Joseph LeonardoMorales Pacheco, Angie MishelMorán Romero, Hjalmar RobertoCueva Fajardo, Angie YarelVacunaCáncerCuelloÚteroSexualVaccineCancerNeckUterusSexualThe human papillomavirus (HPV) causes the most common sexually transmitted viral infection in the world. To date, about 200 types of HPV have been identified. The fundamental purpose of vaccination is to prevent infection by the Human Pap-illomavirus, which is responsible for Cervical Cancer, genital warts and other types of cancer common in genital regions, also reduce the incidence of morbidity and mortality from Neck Cancer. The methodology used for this research work is part of a bibliographic review of a documentary type, since we are going to deal with issues raised at a theoretical level such as the Vaccine against the human papillomavirus. The technique for data collection is made up of electronic materials, the latter such as Google Scholar, PubMed, among others, relying on the use of descriptors in health sciences or MESH terminology. The information obtained here will be reviewed for further analysis. HPV is not an uncommon virus, it is present in both men and women, despite the fact that, in most cases, after a while the virus can disappear on its own, if it persists, without the knowledge in this The case of women can trigger more serious lesions in a period of up to 10 years, such as cervical cancer, cervical cancer, and minor lesions such as warts on the genitals. The HPV vaccine has existed for more than a decade, however, the lack of knowledge about the consequences that this pathology can trigger, together with cul-tural beliefs, parental skepticism, low education, among other aspects, have made the applicability of the vaccine complex. vaccine that the WHO recommends starting at 9 years of age, to once and for all protect adolescents from the onset of sex-ual intercourse, the effectiveness of the vaccine is proven to be more than 90% when the dose is applied recommendedEl virus del papiloma humano (VPH) produce la infección viral transmitida por vía sexual más frecuente del mundo. A la fecha, cerca de 200 tipos de VPH han sido identificados, El propósito fundamental de la vacunación es prevenir la infección por el virus del Papiloma Humano, el cual es responsable del Cáncer de Cuello Uterino, verrugas genitales y otros tipos de cáncer frecuentes en regiones genitales, asimismo reducir la incidencia de la morbilidad y mortalidad por Cáncer de Cuello. La metodología utilizada para el presente trabajo de investigación, se enmarca dentro de una revisión bibliográfica de tipo documental, ya que nos vamos a ocupar de temas planteados a nivel teórico como es Vacuna contra el virus del papiloma humano. La técnica para la recolección de datos está constituida por materiales electrónicos, estos últimos como Google Académico, PubMed, entre otros, apoyándose para ello en el uso de descriptores en ciencias de la salud o terminología MESH. La información aquí obtenida será revisada para su posterior análisis. El VPH no es un virus infrecuente, está presente tanto en hombres como mujeres, a pesar de que, en la mayoría de los casos, al cabo de un tiempo el virus puede desaparecer por sí solo, si este persiste, sin el conocimiento en este caso de la mujer puede desencadenar lesiones más graves en un periodo de hasta 10 años como cáncer de cuello uterino, cervical, y lesiones menores como verrugas en los genitales. La vacuna contra el VPH existe desde hace más de una década, sin embargo, el desconocimiento sobre las consecuencias que puede desencadenar esta patología, unido a creencias culturales, escepticismo de padres, baja educación, entre otros aspectos, han hecho compleja la aplicabilidad de la vacuna que la OMS recomienda su inicio desde los 9 años de edad, para de una vez proteger desde temprana edad a los adolescentes frente a inicio de las relaciones sexuales, la efectividad de la vacuna está probada en más del 90% cuando es aplicada la dosis recomendada.2022text (article)application/pdfhttps://dialnet.unirioja.es/servlet/oaiart?codigo=8512304(Revista) ISSN 2588-073XRECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 3, 2022, pags. 175-182spaLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI